
Sign up to save your podcasts
Or


This Good Practice Paper podcast provides recommendations for the diagnosis, risk stratification and management of the monoclonal gammopathy of undetermined significance (MGUS). It describes the recently recognised entity of the monoclonal gammopathy of clinical significance (MGCS), and recommends how it should be managed. The potential for targeted population screening for MGUS is also discussed.
By British Society for HaematologyThis Good Practice Paper podcast provides recommendations for the diagnosis, risk stratification and management of the monoclonal gammopathy of undetermined significance (MGUS). It describes the recently recognised entity of the monoclonal gammopathy of clinical significance (MGCS), and recommends how it should be managed. The potential for targeted population screening for MGUS is also discussed.

893 Listeners

27 Listeners

649 Listeners

2,787 Listeners

3 Listeners

53 Listeners

14,371 Listeners

3,148 Listeners

906 Listeners

49 Listeners

185 Listeners

33 Listeners

2,221 Listeners

1 Listeners

0 Listeners